Johnson & Johnson

Johnson & Johnson JNJ Stock

$267.61   3.813320%
Add to favorites
Exchange
Market Cap
$644.91B
LOW - HIGH [24H]
$259.04 - $269.67
VOLUME [24H]
$10.13M
P/E Ratio
40.60
Earnings per share
$6.59
ISIN
US4781601046
Price   Prediction

Johnson & Johnson Price Chart

Sorry, that's all we've gotfor now...

Johnson & Johnson JNJ Financial and Trading Overview

Johnson & Johnson stock price 267.61 USD
Previous Close 259.36 USD
Open 257.5 USD
Bid 0 USD x 10000
Ask 0 USD x 30000
Day's Range 254.56 - 257.8 USD
52 Week Range 184.66 - 281.07 USD
Volume 6.19M USD
Avg. Volume 7M USD
Market Cap 621.22B USD
Beta (5Y Monthly) 0.206
PE Ratio (TTM) 39.116844
EPS (TTM) 6.59 USD
Forward Dividend & Yield 5.36 (2.08%)
Ex-Dividend Date November 24, 2026
1y Target Est 279.41 USD

JNJ Valuation Measures

Enterprise Value 649.5B USD
Trailing P/E 39.116844
Forward P/E 22.188938
PEG Ratio (5 yr expected) 2.87
Price/Sales (ttm) 6.253824
Price/Book (mrq) 7.305861
Enterprise Value/Revenue 6.538
Enterprise Value/EBITDA 19.019

Trading Information

Johnson & Johnson Stock Price History

Beta (5Y Monthly) 0.206
52-Week Change 33.93%
S&P500 52-Week Change 15.78%
52 Week High 281.07 USD
52 Week Low 184.66 USD
50-Day Moving Average 265.03 USD
200-Day Moving Average 244.88 USD

JNJ Share Statistics

Avg. Volume (3 month) 7M USD
Avg. Daily Volume (10-Days) 8.3M USD
Shares Outstanding 2.41B
Float 2.41B
Short Ratio 3.46
% Held by Insiders 0.052%
% Held by Institutions 76.73%
Shares Short 22.07M
Short % of Float 1.01%
Short % of Shares Outstanding 0.91%

Dividends & Splits

Trailing Annual Dividend Rate 1.3
Trailing Annual Dividend Yield 0.50%
5 Year Average Dividend Yield 268.00%
Payout Ratio 0.6072
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 28, 2025
Most Recent Quarter (mrq) September 27, 2026
Next Fiscal Year End December 28, 2026

Profitability

Profit Margin 16.20%
Operating Margin (ttm) 25.05%
Gross Margin 67.75%
EBITDA Margin 34.37%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 99.33B USD
Revenue Per Share (ttm) 40.99 USD
Quarterly Revenue Growth (yoy) 5.89%
Gross Profit (ttm) 67.3B USD
EBITDA 34.15B USD
Net Income Avi to Common (ttm) 16.09B USD
Diluted EPS (ttm) 6.59
Quarterly Earnings Growth (yoy) -95.89%

Balance Sheet

Total Cash (mrq) 20.76B USD
Total Cash Per Share (mrq) 8.61 USD
Total Debt (mrq) 49.04B USD
Total Debt/Equity (mrq) 57.71 USD
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 35.284

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Johnson & Johnson

Country United States
State NJ
City New Brunswick
Address One Johnson & Johnson Plaza
ZIP 08933
Phone 732 524 0400
Website https://www.jnj.com
Industry Drug Manufacturers - General
Sector(s) Healthcare
Full Time Employees 138200

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Q&A For Johnson & Johnson Stock

What is a current JNJ stock price?

Johnson & Johnson JNJ stock price today per share is 267.61 USD.

How to purchase Johnson & Johnson stock?

You can buy JNJ shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Johnson & Johnson?

The stock symbol or ticker of Johnson & Johnson is JNJ.

Which industry does the Johnson & Johnson company belong to?

The Johnson & Johnson industry is Drug Manufacturers - General.

How many shares does Johnson & Johnson have in circulation?

The max supply of Johnson & Johnson shares is 2.41B.

What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?

Johnson & Johnson PE Ratio is 40.60849400 now.

What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?

Johnson & Johnson EPS is 6.59 USD over the trailing 12 months.

Which sector does the Johnson & Johnson company belong to?

The Johnson & Johnson sector is Healthcare.

Johnson & Johnson JNJ included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us S&P 500 INDEX SPX US 7663.43 USD —
-1.21
3.59B USD — — — — — — 3.59B USD —
us S&P 500 (Yahoo.com) GSPC US 7663.43 USD —
-1.21
3.56B USD — 7637.36 USD — 7702.94 USD — — 3.56B USD —
us S&P 100 SP100 US 3796.17 USD —
-1.51
1.56B USD — 3785.32 USD — 3824.59 USD — — 1.56B USD —
us Dow Jones Composite Average DJA US 16560.58 USD —
+0.68
698.3M USD — 16358.43 USD — 16568.66 USD — — 698.3M USD —
us Dow Jones Industrial Average DJI US 52867.98 USD —
+0.02
506.2M USD — 52508.38 USD — 52927.88 USD — — 506.2M USD —
us NYSE Arca Pharmaceutical Index DRG US 1319.9 USD —
+1.91
— — — — — — — — —
us NYSE ARCA MAJOR MARKET INDEX XMI US 3944.79 USD —
0
— — — — — — — — —
us US Tech US Broad Dividend Achiev DAA US 4690.68 USD —
+0.74
— — 4644.53 USD — 4692.01 USD — — — —
us NYSE Composite Index NYA US 24275.53 USD —
+0.09
— — — — — — — — —
us Interbrand Best Global Brands I BRAND100 US 971.21 USD —
0
— — 971.21 USD — 971.21 USD — — — —
us US Tech CTA Artificial Intellige NQROBO US 2001.32 USD —
-1.86
— — 1988.82 USD — 2002.95 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3781.71 USD —
-2.06
— — 3758.99 USD — 3821.82 USD — — — —
us US Tech CRD Global Sustainabilit NQCRD US 1735.62 USD —
0
— — 1715.94 USD — 1757.95 USD — — — —
us The Capital Strength Index NQCAPST US 3737.34 USD —
+1.98
— — 3673.26 USD — 3738.5 USD — — — —
us US Tech US Broad Dividend Achiev DAATR US 8845.6 USD —
+0.74
— — 8758.58 USD — 8848.12 USD — — — —
us US Tech OMX CRD Global Sustainab QCRD US 1595.1 USD —
0
— — — — — — — — —
us Interbrand Best Global Brands N BRAND100N US 987.01 USD —
0
— — 987.01 USD — 987.01 USD — — — —
us US Tech US Smart Pharmaceuticals NQSSPH US 2292.11 USD —
+1.09
— — 2259.78 USD — 2303.35 USD — — — —
us Better Investing 100 BIXX US 245.36 USD —
0
— — — — — — — — —
us US Tech US Price Setters Index NQPRCE US 3145.83 USD —
+1.23
— — 3106.77 USD — 3146.32 USD — — — —
$2.72T
Total marketcap
$68.81B
Total volume
BTC 60.02%   •   ETH 10.70%
Dominance
Select currency